References
- Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012; 227: 44-58. doi: 10.1002/jcp.22724
- Linton A, Vardy J, Clarke S, van Zandwijk N. The ticking time-bomb of asbestos: its insidious role in the development of malignant mesothelioma. Crit Rev Oncol Hematol 2012; 84: 200-12. doi: 10.1016/j.critrevonc.2012.03.001
- Franko A, Kotnik N, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V. The influence of genetic variability on the risk of developing malignant mesothelioma. Radiol Oncol 2018; 52: 105-11. doi: 10.2478/raon-2018-0004
- Remon J, Lianes P, Martinez S, Velasco M, Querol R, Zanui M. Malignant mesothelioma: new insights into a rare disease. Cancer Treat Rev 2013; 39: 584-91. doi: 10.1016/j.ctrv.2012.12.005
- Franko A, Dolzan V, Kovac V, Arneric N, Dodic-Fikfak M. Soluble mesothelinrelated peptides levels in patients with malignant mesothelioma. Dis Markers 2012; 32: 123-31. doi: 10.3233/DMA-2011-0866
- Weiner SJ, Neragi-Miandoab S. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J Cancer Res Clin Oncol 2009; 135: 15-27. doi: 10.1007/s00432-008-0444-9
- Zellos L, Christiani DC. Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin 2004; 14: 469-77, viii. doi: 10.1016/j. thorsurg.2004.06.011
- Sen D. Working with asbestos and the possible health risks. Occup Med (Lond) 2015; 65: 6-14. doi: 10.1093/occmed/kqu175
- Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 2007; 45: 379-87. doi: 10.2486/ indhealth.45.379
- Case BW, Abraham JL, Meeker G, Pooley FD, Pinkerton KE. Applying definitions of “asbestos” to environmental and “low-dose” exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev 2011; 14: 3-39. doi: 10.1080/10937404.2011.556045
- Toyokuni S. Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci 2009; 71: 1-10. doi: 10.1265/jjh.66.562
- Upadhyay D, Kamp DW. Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp Biol Med (Maywood) 2003; 228: 650-9. doi: 10.1177/153537020322800602
- Manning CB, Vallyathan V, Mossman BT. Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2002; 2: 191-200. doi: 10.1016/S1567-5769(01)00172-2
- Dianzani I, Gibello L, Biava A, Giordano M, Bertolotti M, Betti M, et al. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat Res 2006; 599: 124-34. doi: 10.1016/j.mrfmmm.2006.02.005
- Betti M, Ferrante D, Padoan M, Guarrera S, Giordano M, Aspesi A, et al. XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study. Mutat Res 2011; 708: 11-20. doi: 10.1016/j.mrfmmm.2011.01.001
- Spivak G. Nucleotide excision repair in humans. DNA Repair (Amst) 2015; 36: 13-8. doi: 10.1016/j.dnarep.2015.09.003
- Zhang L, Wang J, Xu L, Zhou J, Guan X, Jiang F, et al. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis. Mutagenesis 2012; 27: 67-76. doi: 10.1093/mutage/ger062
- Zhao Z, Zhang A, Zhao Y, Xiang J, Yu D, Liang Z, et al. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility. Biosci Rep 2018; 38(3): BSR20180114. doi: 10.1042/BSR20180114
- Manandhar M, Boulware KS, Wood RD. The ERCC1 and ERCC4 (XPF) genes and gene products. Gene 2015; 569: 153-61. doi: 10.1016/j. gene.2015.06.026
- Ding YW, Gao X, Ye DX, Liu W, Wu L, Sun HY. Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies. Clin Transl Oncol 2015; 17: 710-9. doi: 10.1007/s12094-015-1298-7
- Li B, Shi X, Yuan Y, Peng M, Jin H, Qin D. ERCC1 rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individuals. Biosci Rep 2018; 38(3): BSR20180440. doi: 10.1042/BSR20180440
- Chen J, Sun N, Hu G, Chen X, Jiang J, Wu H, et al. Association of ERCC1 polymorphisms with the risk of colorectal cancer: a meta-analysis. Crit Rev Eukaryot Gene Expr 2017; 27(3): 267-75. doi: 10.1615/ CritRevEukaryotGeneExpr.2017019713
- De Mattia E, Cecchin E, Polesel J, Bignucolo A, Roncato R, Lupo F, et al. Genetic biomarkers for hepatocellular cancer risk in a caucasian population. World J Gastroenterol 2017; 23: 6674-84. doi: 10.3748/wjg.v23.i36.6674
- London RE. The structural basis of XRCC1-mediated DNA repair. DNA repair. 2015; 30: 90-103. doi: 10.1016/j.dnarep.2015.02.005
- Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003; 2: 901-8. doi: 10.1016/S1568-7864(03)00085-5
- Srivastava A, Srivastava K, Pandey SN, Choudhuri G, Mittal B. Singlenucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population. Ann Surg Oncol 2009; 16: 1695-703. doi: 10.1245/s10434-009-0354-3
- Jafari Nedooshan J, Forat Yazdi M, Neamatzadeh H, Zare Shehneh M, Kargar S, Seddighi N. Genetic association of XRCC1 gene rs1799782, rs25487 and rs25489 polymorphisms with risk of thyroid cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2017; 18: 263-70. doi: 10.22034/ APJCP.2017.18.1.263
- Zhu DQ, Zou Q, Hu CH, Su JL, Zhou GH, Liu P. XRCC1 genetic polymorphism acts a potential biomarker for lung cancer. Tumour Biol 2015; 36: 3745-50. doi: 10.1007/s13277-014-3014-6
- Dodic Fikfak M, Kriebel D, Quinn MM, Eisen EA, Wegman DH. A case control study of lung cancer and exposure to chrysotile and amphibole at a slovenian asbestos-cement plant. Ann Occup Hyg 2007; 51: 261-8. doi: 10.1093/annhyg/mem003
- Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960; 17: 260-71.
- Muscat JE, Wynder EL. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 1991; 51: 2263-7.
- Berry G, Newhouse ML, Antonis P. Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Br J Ind Med 1985; 42: 12-8.
- Lacourt A, Leveque E, Guichard E, Gilg Soit Ilg A, Sylvestre MP, Leffondre K. Dose-time-response association between occupational asbestos exposure and pleural mesothelioma. Occup Environ Med 2017; 74: 691-7. doi: 10.1136/oemed-2016-104133
- Ulvestad B, Kjaerheim K, Martinsen JI, Damberg G, Wannag A, Mowe G, et al. Cancer incidence among workers in the asbestos-cement producing industry in Norway. Scand J Work Environ Health 2002; 28: 411-7. doi: 10.5271/sjweh.693